New market research report published by iHealthcareAnalyst, Inc., estimates Angioplasty Balloons Market – Global Product and Materials Analysis and Forecast 2017-2021, the as global angioplasty balloons market growing at the rate of 4.5% CAGR and estimated to reach US$ 2.1 Billion by 2021 due to high prevalence of coronary artery diseases and geriatric population.
Browse Angioplasty Balloons Market – Global Product and Materials Analysis and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/angioplasty-balloons-market/
Angioplasty balloons widens the narrow or obstructed blood vessel using a balloon catheter to treat atherosclerosis (blood vessel obstructions). The angioplasty balloons market report estimates the market size (Revenue US$ million – 2014 to 2021) for key market segments based on balloon type (normal, cutting, drug coated and scoring balloons), materials used (non-compliant and semi-compliant balloons), and forecasts growth trends (CAGR% – 2017 to 2021). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
The global angioplasty balloons market is segmented as:
- Balloon Type
- Cutting Balloon
- Drug coated Balloon
- Normal Balloon
- Scoring Balloon
- Material Type
- Non-compliant Balloon
- Semi-compliant Balloon
- Geography (Region, Country)
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Rest of LA)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Rest of the World
- Company Profiles
- Abbott Vascular
- BIOTRONIK SE & Co.KG
- Boston Scientific Corporation
- R. Bard, Inc.
- Cook Medical, Inc.
- ENDOCOR GmbH
- Johnson & Johnson (Cordis Corporation)
- Medtronic, plc
- NATEC Medical Limited
- Spectranetics Corporation
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.